Comparison of Pseudomonas aeruginosa strains reveals that Exolysin A toxin plays an additive role in virulence
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Pseudomonas aeruginosa strains reveals that Exolysin A toxin plays an additive role in virulence
Authors
Keywords
-
Journal
Pathogens and Disease
Volume 78, Issue 1, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-02-19
DOI
10.1093/femspd/ftaa010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deprivation of the Periplasmic Chaperone SurA Reduces Virulence and Restores Antibiotic Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa
- (2019) Kristina Klein et al. Frontiers in Microbiology
- RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference
- (2019) Alexey M Kozlov et al. BIOINFORMATICS
- cAMP and Vfr Control Exolysin Expression and Cytotoxicity of Pseudomonas aeruginosa Taxonomic Outliers
- (2018) Alice Berry et al. JOURNAL OF BACTERIOLOGY
- Early Infections Complicating the Care of Combat Casualties from Iraq and Afghanistan
- (2018) Amy C. Weintrob et al. Surgical Infections
- Multiple Pseudomonas species secrete exolysin-like toxins and provoke Caspase-1-dependent macrophage death
- (2017) Pauline Basso et al. ENVIRONMENTAL MICROBIOLOGY
- Successful treatment of Pseudomonas aeruginosa osteomyelitis with antibiotic monotherapy of limited duration
- (2017) Nadir Laghmouche et al. JOURNAL OF INFECTION
- Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems
- (2017) Chia-Hsin Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008–2012
- (2017) Abaigeal D. Jackson et al. PHARMACOECONOMICS
- Correction: Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus
- (2017) Richard D. Waite et al. PLoS One
- Emergence of Antimicrobial Resistance among Pseudomonas aeruginosa: Implications for Therapy
- (2017) George Zhanel et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis
- (2017) Pauline Basso et al. mBio
- Pseudomonas aeruginosa Exolysin promotes bacterial growth in lungs, alveolar damage and bacterial dissemination
- (2017) Stéphanie Bouillot et al. Scientific Reports
- Exolysin Shapes the Virulence of Pseudomonas aeruginosa Clonal Outliers
- (2017) Emeline Reboud et al. Toxins
- Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
- (2017) Erlangga Yusuf et al. Annals of Intensive Care
- Phenotype and toxicity of the recently discovered exlA -positive Pseudomonas aeruginosa strains collected worldwide
- (2016) Emeline Reboud et al. ENVIRONMENTAL MICROBIOLOGY
- Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model
- (2016) Mehdi Mousavi et al. MICROBIAL PATHOGENESIS
- Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years
- (2015) Liang-An Chen et al. CHINESE MEDICAL JOURNAL
- Chronic wound infections: the role ofPseudomonas aeruginosaandStaphylococcus aureus
- (2015) Raffaele Serra et al. Expert Review of Anti-Infective Therapy
- Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains
- (2015) Louise Cullen et al. MICROBIOLOGY-SGM
- Urinary tract infections: epidemiology, mechanisms of infection and treatment options
- (2015) Ana L. Flores-Mireles et al. NATURE REVIEWS MICROBIOLOGY
- Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome
- (2015) Paul Loubet et al. Infectious Diseases
- A Type III Secretion Negative Clinical Strain of Pseudomonas aeruginosa Employs a Two-Partner Secreted Exolysin to Induce Hemorrhagic Pneumonia
- (2014) Sylvie Elsen et al. Cell Host & Microbe
- Ventilator-associated pneumonia after cardiac surgery: A meta-analysis and systematic review
- (2014) Siyi He et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Cheating by type 3 secretion system-negative Pseudomonas aeruginosa during pulmonary infection
- (2014) K. Czechowska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Respiratory infections in patients undergoing mechanical ventilation
- (2014) Jordi Rello et al. Lancet Respiratory Medicine
- Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit
- (2014) Kaweesak Chittawatanarat et al. Infection and Drug Resistance
- Cystic Fibrosis-Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts
- (2012) Nicola Ivan Lorè et al. PLoS One
- Economic burden ofPseudomonas aeruginosainfection in patients with cystic fibrosis
- (2011) Sujit S. Sansgiry et al. JOURNAL OF MEDICAL ECONOMICS
- Microtiter Dish Biofilm Formation Assay
- (2011) George A. O'Toole Jove-Journal of Visualized Experiments
- Pan-genome sequence analysis using Panseq: an online tool for the rapid analysis of core and accessory genomic regions
- (2010) Chad Laing et al. BMC BIOINFORMATICS
- The Pseudomonas aeruginosa Vfr Regulator Controls Global Virulence Factor Expression through Cyclic AMP-Dependent and -Independent Mechanisms
- (2010) E. L. Fuchs et al. JOURNAL OF BACTERIOLOGY
- Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates
- (2010) T. S. Murray et al. JOURNAL OF MEDICAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started